We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Ruairi J Mackenzie

Ruairi J Mackenzie

Senior Science Writer

Contact Us

Ruairi started with Technology Networks in January 2018 after completing an undergraduate degree in neuroscience at the University of Edinburgh and a master’s degree in clinical neuroscience from the University of Cambridge. As senior science writer, Ruairi covers a range of scientific news and articles, with a focus on the complexities and curiosities of the brain. Ruairi also looks after search engine optimization (SEO) efforts on Technology Networks and created the site’s podcast, Opinionated Science, in 2020.


Latest Content
Geneticists Are One Step Closer to Understanding Neurodevelopmental Disorders
News

Geneticists Are One Step Closer to Understanding Neurodevelopmental Disorders

Researchers studying the genetic origins of neurodevelopmental disorders have picked apart the pathways that underlie an incredibly rare congenital syndrome, a finding which the authors hope can be applied to related conditions such as autism spectrum disorder (ASD).
RNA-seq in Neuroscience
Infographic

RNA-seq in Neuroscience

RNA-seq has shown its worth across many fields, and neuroscience is no exception. In this infographic, we’ll investigate RNA-seq, how it is used in neuroscience, and how it has the potential to advance our understanding of every cell in the brain.
The Booming Business of Neurotoxin Therapy
Industry Insight

The Booming Business of Neurotoxin Therapy

Botulinum neurotoxins are widely used in both therapeutic and cosmetic applications, but Ipsen says that their new rBoNT-E toxin is a step up from compounds based on the much more widely used serotype A toxin. We spoke to Ipsen Senior Vice President Neurosciences R&D, Philippe Picaut, to find out more.
Neuroticism Could Lead to Depression, Says Largest-ever Genetic Analysis
News

Neuroticism Could Lead to Depression, Says Largest-ever Genetic Analysis

A new study has leveraged genetic datasets to uncover genes linked to depression. The research identified 269 genes associated with the condition. Scientists also deployed innovative statistical techniques to connect specific behaviors to depression. Their analysis provides evidence that neurotic behaviors could lead people to become depressed.
The Biggest Challenges for Data Integrity
Industry Insight

The Biggest Challenges for Data Integrity

Ensuring that data is reliable, reproducible, and therefore valuable means companies in both regulated and non-regulated spaces must keep data integrity at the heart of their informatics operations. We talked to John Zenk, Validation Services Manager at laboratory informatics consultancy CSols, Inc, to find out what the biggest concerns in data integrity are and how companies can take steps to overcome these challenges.
Can We Treat Mood Disorders with Pharmacological Therapeutics?
Industry Insight

Can We Treat Mood Disorders with Pharmacological Therapeutics?

Clinical treatments for neurological and mood disorders like social anxiety disorder and major depressive disorder have failed to show consistent efficacy in treating patients. VistaGen Therapeutics is aiming to correct that. We talked to VistaGen’s CEO, Shawn Singh, about the need for treatments in this area and why Vistagen thinks their compounds AV-101 and PH94B could be promising therapies.
Supporting Drug Discovery with Cell-centered Models of the Immune System
Industry Insight

Supporting Drug Discovery with Cell-centered Models of the Immune System

Many biological processes, specifically the immune system, operate at a cellular level. CytoReason have harnessed this knowledge to build computational, high-resolution, mechanistic models for a range of diseases that enables better discovery and validation of drug targets.
ROCKbusting Huntington’s and Probing Parkinson’s
Article

ROCKbusting Huntington’s and Probing Parkinson’s

At the Society for Neuroscience (SfN) conference last held in November 2018 in San Diego, a truly frightening number of posters were presented over nine sessions. In this article we look in-depth at posters shared by Charles River Laboratories, highlighting research into Huntington's Disease and Parkinson's Disease.
Microfluidics Solutions to Proteomics Problems
Industry Insight

Microfluidics Solutions to Proteomics Problems

Microfluidic platforms are becoming commonplace across biological science. To find out more about how microfluidic technology is revolutionizing protein analysis, we spoke to Tuomas Knowles, Founder and Chief Scientific Officer, Fluidic Analytics.
Building a Smart City
Industry Insight

Building a Smart City

Cities often don't work very well. Bins don't get collected. Traffic queues are long. Shops run out of goods. The Russian team behind Airalab think that AI can help streamline cities and the economy more widely. Their Robonomics platform aims to make it easier to bring automated, intelligent technology into the economy. With Smart City projects already on the go, from Dubai to Milton Keynes, we spoke to Airalab's Aleksandr Kapitonov to find out more.
Advertisement